1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Notice of Special Interest (NOSI): Encouraging Women's Health Research within the NIDCD Mission Areas" is currently closed and not accepting applications.
Notice of Special Interest (NOSI): Encouraging Women's Health Research within the NIDCD Mission Areas is sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH). This notice solicits grant applications seeking to improve women's health across the lifespan within the scope of NIDCD's mission.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Expired NOT-DC-23-006: Notice of Special Interest (NOSI): Encouraging Womens Health Research within the NIDCD Mission Areas This notice has expired. Check the NIH Guide for active opportunities and notices.
Notice of Special Interest (NOSI): Encouraging Womens Health Research within the NIDCD Mission Areas First Available Due Date: New Date September 9, 2025 (Prior Date PAR-21-063 - NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required) PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PAR-21-357 - Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) PAR-22-060 - Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) PAR-21-154 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required) PAR-21-155 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) PAR-21-107 - NIDCD Early Career Research (ECR) Award (R21 Clinical Trial Optional) Please note: For PAR-21-107, the PD/PI must be no more than 7-years from the date the terminal degree was received.
Read the NOFO carefully for specific details and exceptions.
PA-20-194 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) National Institute on Deafness and Other Communication Disorders ( NIDCD ) Research Objective and Scope Communication disorders can have a significant impact on womens overall health and well-being affecting their ability to engage in daily activities, participate in society and immerse in the workforce.
Because communication disorders can affect the physical, emotional, social, recreational, educational, and vocational aspects of life, women may experience health disparities due to one of any combination of these conditions which can impact quality of life. The goal of this NOSI is to stimulate research focused on the health of women within the NIDCD mission areas.
To better understand these issues and to develop effective interventions, NIDCD is seeking research applications that focus on the intersection between the health of women and their ability to hear, maintain balance, taste, smell, use of their voice, produce and understand speech and language across all ages, geographic distributions, ethnicities, race, and socioeconomic status.
This may include studies that investigate the underlying causes of these health states, their impact on womens health and well-being, and strategies for preventing, mitigating, or treating these conditions in women. Applications submitted in response to this NOSI should be relevant to the mission of NIDCD.
For example, research on hearing, balance, taste, smell, voice, speech and/or language that are appropriate to this NOSI include, but are not limited to: Expanding the understanding of sex differences impacting hearing loss, balance disorders, taste and smell abnormalities, voice disorders, speech, and language disorders .
The prevalence, incidence, and natural history of hearing loss, balance disorders, taste and smell abnormalities, voice disorders, speech disorders, and language disorders in women. The physiological and psychological factors that contribute to the development or progression of communication disorders in women. The impact of communication disorders on womens overall health and well-being.
The development and evaluation of interventions or treatment strategies, including pharmacological, behavioral, social, surgical and technology-driven approaches, for preventing, mitigating, or treating conditions impacting women in NIDCD mission areas. This notice applies to due dates on or after May 5, 2023 and subsequent receipt dates through May 6, 2026.
Potential applicants to this NOSI are strongly encouraged to contact Scientific/Research staff prior to submission.
PAR-21-063 - NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required) PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PAR-21-357 - Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) PAR-22-060 - Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) PAR-21-154 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required) PAR-21-155 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) PAR-21-107 - NIDCD Early Career Research (ECR) Award (R21 Clinical Trial Optional) Please note: For PAR-21-107 , the PD/PI must be no more than 7-years from the date the terminal degree was received.
Read the NOFO carefully for specific details and exceptions.
PA-20-194 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) All instructions in the SF424 (R&R) Application Guide and the funding opportunity announcement used for submission must be followed, with the following additions: For funding consideration, applicants must include NOT-DC-23-006 (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form.
Applications without this information in box 4B will not be considered for this initiative. Applications nonresponsive to terms of this NOSI will not be considered for the NOSI initiative.
Please direct all inquiries to the contacts in Section VII of the listed funding opportunity announcements with the following additions/substitutions: Scientific/Research Contact(s) National Institute on Deafness and Other Communication Disorders ( NIDCD ) Examine your eRA Commons account for review assignment and contact information (information appears two weeks after the submission due date).
Financial/Grants Management Contact(s) National Institute on Deafness and Other Communication Disorders (NIDCD) Weekly TOC for this Announcement NIH... Turning Discovery Into Health ®
According to the current listing, eligibility includes: Applicants for research grants aligned with the NIDCD mission and focused on women's health. Confirm the full requirements in the official notice before applying.
The published deadline was May 5, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Notice of Special Interest (NOSI): Encouraging Women's Health Research within the NIDCD Mission Areas is funded by National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
ARPA-H launched SPECTRA on September 17, 2026 under solicitation ARPA-H-SOL-26-163 — four technical areas with separate Solution Summary deadlines on October 18, December 2, and January 18. The enabling-technologies area closes first, five weeks after launch. Here is why the sequencing matters and how to read each TA.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article